News from AVACEN Medical:
AVACEN Medical Announces Support for New ClinicalTrials.gov Initiative
Reporting Simplification Encouraged SAN DIEGO, Oct. 13, 2016 /PRNewswire/ — Today AVACEN Medical (AVACEN), a medical device company, whose fibromyalgia clinical trial results can be found on ClinicalTrials.gov, announced it strongly supports the new rule and steps taken by the National Institutes of Health (NIH) to expand and enforce the requirement of clinical trial results publication on […]
AVACEN Medical Selected for 2016 MetroConnect Grant
SAN DIEGO, July 5, 2016 /PRNewswire/ — San Diego Mayor Kevin Faulconer and World Trade Center San Diego have announced that AVACEN Medical has been selected to take part in the MetroConnect Program, a comprehensive export support program run by the World Trade Center San Diego. The Program is designed to help San Diego companies […]
AVACEN Medical Engages Investment Banker
Qualified Purchaser Sought SAN DIEGO, Dec. 22, 2015 /PRNewswire/ — AVACEN Medical today announced it has formally retained Objective Capital Partners, LLC to locate a qualified purchaser to acquire the Company. Photo – http://photos.prnewswire.com/prnh/20151222/317765 Logo – http://photos.prnewswire.com/prnh/20151222/317766LOGO AVACEN Medical is a company involved in research and development related to medical devices designed to use its […]
Encouraging Fibromyalgia Study Results Now Available at ClinicalTrials.gov
SAN DIEGO, Dec. 11, 2015 /PRNewswire/ — AVACEN Medical announced today that ClinicalTrials.gov, a service of the U.S. National Institutes of Health, has published the results of the Company's Fibromyalgia clinical trials. ClinicalTrials.gov is a web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on […]
New Concept for Chronic Pain Treatment Patent Issued
SAN DIEGO, Nov. 25, 2015 /PRNewswire/ — Today AVACEN Medical announced the issue of United States patent No. 9,192,509 entitled: "Methods and Apparatus for Therapeutic Application of Thermal Energy Including Blood Viscosity Adjustment". This patent shields the company's AVACEN 100 dry heat therapy medical device and specific methods of use, referred to by the company as […]
Drug-Free, Rapid Whole-Body Muscle Relaxation Solution to be Introduced at "PAINWeek" in Las Vegas
A Cost Effective Means to Combat the Prescription Drug Overdose Epidemic. SAN DIEGO, Sept. 8, 2015 /PRNewswire/ — AVACEN Medical announced today that it will be introducing its FDA cleared noninvasive AVACEN 100 muscle relaxation medical device at PAINWeek on September 9, 2015. PAINWeek is the largest US pain conference for frontline practitioners with an interest […]
Novel FDA-Cleared AVACEN 100 Medical Device SAN DIEGO, July 1, 2015 /PRNewswire/ — AVACEN, Inc. announced today the issue by the US Patent Office of a second AVACEN patent covering the medical technology platform supporting its unique Dry Heat Therapy AVACEN 100 product. Logo – http://photos.prnewswire.com/prnh/20150630/227364LOGO The apparatus and methods patent no. 9,066,781 – Methods And […]
SAN DIEGO, Dec. 30, 2014 /PRNewswire/ — AVACEN Medical announced today that it has launched a $2 million campaign on Crowdfunder.com to support further company clinical trials and FDA applications. This is in response to the encouraging outcomes of an AVACEN sponsored pilot and a follow-up fibromyalgia study involving 22 subjects and separate anecdotal results relating […]
AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode
Monitors Proper Device Use and Enhances Patient Compliance SAN DIEGO, Oct. 22, 2014 /PRNewswire/ — AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 (k) OTC clearance by the U.S. Food and Drug Administration. This clearance allows the AVACEN 100 to be marketed over the Internet for: the temporary relief […]
